These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28898185)

  • 1. Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.
    Nishino M; Hatabu H; Sholl LM; Ramaiya NH
    Radiographics; 2017; 37(5):1371-1387. PubMed ID: 28898185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of Drug-Related Pneumonitis in Oncology.
    Tseng SC; Lee HY; Nishino M
    Semin Respir Crit Care Med; 2022 Dec; 43(6):887-898. PubMed ID: 36307109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review of the Mechanisms and Clinical Implications of Precision Cancer Therapy-Related Toxicity: A Primer for the Radiologist.
    Thomas R; Howard SA; Laferriere SL; Braschi-Amirfarzan M
    AJR Am J Roentgenol; 2020 Sep; 215(3):770-780. PubMed ID: 32755160
    [No Abstract]   [Full Text] [Related]  

  • 4. Interprofessional Management of Toxicities Related to Cancer Precision Medicine.
    Abueg KD
    Semin Oncol Nurs; 2017 Nov; 33(4):376-383. PubMed ID: 28927762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of Precision Therapy for Lung Cancer: Current State of the Art.
    Park H; Sholl LM; Hatabu H; Awad MM; Nishino M
    Radiology; 2019 Oct; 293(1):15-29. PubMed ID: 31385753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting Risk and Benefit in Early Oncology Trials in the Era of Precision Medicine: A Systematic Review and Meta-Analysis of Phase I Trials of Targeted Single-Agent Anticancer Therapies.
    Mackley MP; Fernandez NR; Fletcher B; Woolcott CG; Fernandez CV
    JCO Precis Oncol; 2021 Nov; 5():17-26. PubMed ID: 34994588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiothoracic Complications of Immune Checkpoint Inhibitor Therapy: An Imaging Review.
    Agarwal S; Healey TT
    J Comput Assist Tomogr; 2020; 44(5):652-655. PubMed ID: 32842069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of Histiocytosis in the Era of Genomic Medicine.
    Park H; Nishino M; Hornick JL; Jacobsen ED
    Radiographics; 2019; 39(1):95-114. PubMed ID: 30500304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and Clinical Approach to Intra-abdominal Adverse Effects of Targeted Cancer Therapies.
    Chang ST; Menias CO; Lubner MG; Mellnick VM; Hara AK; Desser TS
    Radiographics; 2017; 37(5):1461-1482. PubMed ID: 28753381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninfectious Granulomatous Diseases of the Chest.
    Naeem M; Ballard DH; Jawad H; Raptis C; Bhalla S
    Radiographics; 2020; 40(4):1003-1019. PubMed ID: 32501738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of targeted drug therapies for solid malignancies: manifestations and mechanisms.
    Abramson RG; Abramson VG; Chan E; Horn L; Keedy VL; Pao W; Sosman JA
    AJR Am J Roentgenol; 2013 Mar; 200(3):475-83. PubMed ID: 23436834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know.
    Braschi-Amirfarzan M; Tirumani SH; Hodi FS; Nishino M
    Korean J Radiol; 2017; 18(1):42-53. PubMed ID: 28096717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity.
    Torrisi JM; Schwartz LH; Gollub MJ; Ginsberg MS; Bosl GJ; Hricak H
    Radiology; 2011 Jan; 258(1):41-56. PubMed ID: 21183492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events of targeted anticancer therapies: what radiologists need to know.
    López Sala P; Alberdi Aldasoro N; Unzué García-Falces G
    Radiologia (Engl Ed); 2020; 62(3):229-242. PubMed ID: 32057481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted agents in the management of small cell lung cancer - present and future.
    Srivastava R; Lebowicz Y; Jamil MO
    Drugs Today (Barc); 2018 Aug; 54(8):479-488. PubMed ID: 30209442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular toxicity associated with chemotherapy and molecular targeted therapy: what should a radiologist know?
    Rohatgi S; Jagannathan JP; Rosenthal MH; Kim KW; Ramaiya NH; Krajewski KM
    AJR Am J Roentgenol; 2014 Dec; 203(6):1353-62. PubMed ID: 25415715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine.
    Bashraheel SS; Domling A; Goda SK
    Biomed Pharmacother; 2020 May; 125():110009. PubMed ID: 32106381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced Renal Cell Carcinoma: Role of the Radiologist in the Era of Precision Medicine.
    Shinagare AB; Krajewski KM; Braschi-Amirfarzan M; Ramaiya NH
    Radiology; 2017 Aug; 284(2):333-351. PubMed ID: 28723287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's the Price? Toxicities of Targeted Therapies in Breast Cancer Care.
    Anders CK; LeBoeuf NR; Bashoura L; Faiz SA; Shariff AI; Thomas A
    Am Soc Clin Oncol Educ Book; 2020 May; 40():55-70. PubMed ID: 32421449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Related Pneumonitis in the Era of Precision Cancer Therapy.
    Nishino M; Hatabu H; Hodi FS; Ramaiya NH
    JCO Precis Oncol; 2017; 1():. PubMed ID: 32913972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.